<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
<title>Clearpoint Neuro Inc — News on 6ix</title>
<link>https://6ix.com/company/clearpoint-neuro-inc</link>
<description>Latest news and press releases for Clearpoint Neuro Inc on 6ix.</description>
<language>en-us</language>
<lastBuildDate>Wed, 29 Apr 2026 20:05:00 GMT</lastBuildDate>
<generator>6ix RSS</generator>
<atom:link href="https://6ix.com/rss/company/clearpoint-neuro-inc" rel="self" type="application/rss+xml" />
<image>
<url>https://6ix-events-pro.s3.amazonaws.com/6ixvideo/logos/org-logo6835567c78dffbe2df0e9c2f.webp</url>
<title>Clearpoint Neuro Inc</title>
<link>https://6ix.com/company/clearpoint-neuro-inc</link>
</image>
<item>
<title>ClearPoint Neuro to Announce First Quarter 2026 Results May 13, 2026</title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-to-announce-first-quarter-2026-results-may-13-2026</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-to-announce-first-quarter-2026-results-may-13-2026</guid>
<pubDate>Wed, 29 Apr 2026 20:05:00 GMT</pubDate>
<description>SOLANA BEACH, CA / ACCESS Newswire / April 29, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that it will release ...</description>
</item>
<item>
<title>ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint</title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-fda-clearance-of-the-velocity-alphar-mr-high-speed-surgical-drill-system-and-first-clinical-use-further-expanding-our-drug-delivery-ecosystem-and-global-footprint</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-fda-clearance-of-the-velocity-alphar-mr-high-speed-surgical-drill-system-and-first-clinical-use-further-expanding-our-drug-delivery-ecosystem-and-global-footprint</guid>
<pubDate>Wed, 22 Apr 2026 20:05:00 GMT</pubDate>
<description>SOLANA BEACH, CA / ACCESS Newswire / April 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced the successful completion ...</description>
</item>
<item>
<title>ClearPoint Neuro Announces Canadian Approval for its Navigation System Further Expanding Our Drug Delivery Ecosystem and Global Footprint</title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-canadian-approval-for-its-navigation-system-further-expanding-our-drug-delivery-ecosystem-and-global-footprint</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-canadian-approval-for-its-navigation-system-further-expanding-our-drug-delivery-ecosystem-and-global-footprint</guid>
<pubDate>Mon, 20 Apr 2026 04:00:00 GMT</pubDate>
<description>Combined clearance of the navigation and drug delivery technologies enables Canadian neurosurgery centers to leverage the Company's flagship image-guidance</description>
</item>
<item>
<title>ClearPoint Neuro Reports Fourth Quarter and Full Year 2025 Results </title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-reports-fourth-quarter-and-full-year-2025-results</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-reports-fourth-quarter-and-full-year-2025-results</guid>
<pubDate>Tue, 17 Mar 2026 04:00:00 GMT</pubDate>
<description>Record Revenue and IRRAS Holdings Acquisition Highlight the Company's 'Fast. Forward.' Strategy SOLANA BEACH, CA / ACCESS Newswire / March 17, 2026 /</description>
</item>
<item>
<title>ClearPoint Neuro to Announce Fourth Quarter and Full Year 2025 Results March 17, 2026</title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2025-results-march-17-2026-27</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-to-announce-fourth-quarter-and-full-year-2025-results-march-17-2026-27</guid>
<pubDate>Fri, 06 Mar 2026 05:00:00 GMT</pubDate>
<description>SOLANA BEACH, CA / ACCESS Newswire / March 6, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling</description>
</item>
<item>
<title>ClearPoint Neuro Announces EU MDR Certification for ClearPoint Navigation Software Version 3.0.2, Expanding Access to the Latest Operating Room Navigation Platform in Europe</title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-eu-mdr-213000202</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-eu-mdr-213000202</guid>
<pubDate>Thu, 22 Jan 2026 21:30:00 GMT</pubDate>
<description>SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced it has ...</description>
</item>
<item>
<title>ClearPoint Neuro Announces Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue</title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-preliminary-unaudited-133000382</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-preliminary-unaudited-133000382</guid>
<pubDate>Mon, 12 Jan 2026 13:30:00 GMT</pubDate>
<description>The Company Achieved 20% Comparable Sales Growth in the Fourth Quarter of 2025 at $10.4 Million SOLANA BEACH, CALIFORNIA / ACCESS Newswire / January 12, 2026 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling ...</description>
</item>
<item>
<title>ClearPoint Neuro Completes Acquisition of IRRAS</title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-completes-acquisition-irras-2025-11-20</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-completes-acquisition-irras-2025-11-20</guid>
<pubDate>Thu, 20 Nov 2025 05:00:00 GMT</pubDate>
<description>Acquisition Will Enhance ClearPoint Neuro's Commercial Scale, Drive Operational Leverage, and Support Its Long-Term Strategy in CNS Drug Delivery Innovation</description>
</item>
<item>
<title>ClearPoint Neuro Reports Third Quarter 2025 Results</title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-reports-third-quarter-2025-results-2025-11-06</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-reports-third-quarter-2025-results-2025-11-06</guid>
<pubDate>Thu, 06 Nov 2025 05:00:00 GMT</pubDate>
<description>Site Readiness Continues for Specialized Treatment Centers Envisioned to Support a Growing Number of Cell and Gene Therapy Trial Patients and Later</description>
</item>
<item>
<title>ClearPoint Neuro Announces Agreement to Acquire IRRAS</title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-agreement-acquire-irras-2025-11-06</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-agreement-acquire-irras-2025-11-06</guid>
<pubDate>Thu, 06 Nov 2025 05:00:00 GMT</pubDate>
<description>Acquisition Will Further Expand the Potential of ClearPoint Neuro's Drug Delivery Portfolio While Immediately Adding New Indications and Commercial Scale</description>
</item>
<item>
<title>ClearPoint Neuro to Participate in Multiple Global Healthcare Conferences in the Fourth Quarter of 2025</title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-participate-multiple-global-healthcare-conferences-fourth-quarter</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-participate-multiple-global-healthcare-conferences-fourth-quarter</guid>
<pubDate>Wed, 05 Nov 2025 05:00:00 GMT</pubDate>
<description>President and CEO Joe Burnett Interview Highlighted on Bloomberg Intelligence Vanguards of Healthcare Podcast TodaySOLANA BEACH, CA / ACCESSWIRE / October 31,</description>
</item>
<item>
<title>ClearPoint Neuro Announces Promising Results from Brain Tumor Laser Therapy Study to be Presented at the CNS Annual Meeting in Los Angeles</title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-promising-results-brain-tumor-laser-therapy-study-be</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-promising-results-brain-tumor-laser-therapy-study-be</guid>
<pubDate>Tue, 07 Oct 2025 04:00:00 GMT</pubDate>
<description>SOLANA BEACH, CALIFORNIA / ACCESS Newswire / October 7, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene</description>
</item>
<item>
<title>ClearPoint Neuro Announces Expanded International Clearances for Key Therapy Delivery Product; Now Totaling 34 Countries Worldwide</title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-expanded-international-clearances-key-therapy-delivery</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-expanded-international-clearances-key-therapy-delivery</guid>
<pubDate>Mon, 06 Oct 2025 04:00:00 GMT</pubDate>
<description>The clearly established history across global regulatory bodies is expected to de-risk BioPharma partners' pathways towards achieving global scale and</description>
</item>
<item>
<title>ClearPoint Neuro Announces Development and Demonstration of the Company's Proprietary Robotic Neuro-Navigation System</title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-development-and-demonstration-companys-proprietary-robotic</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-development-and-demonstration-companys-proprietary-robotic</guid>
<pubDate>Wed, 01 Oct 2025 04:00:00 GMT</pubDate>
<description>New Product Category Will Enable Added Flexibility to Support Commercial Launches of Cell and Gene Therapy SOLANA BEACH, CALIFORNIA / ACCESS Newswire /</description>
</item>
<item>
<title>ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer</title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-appointment-dr-200500397</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-appointment-dr-200500397</guid>
<pubDate>Thu, 25 Sep 2025 20:05:00 GMT</pubDate>
<description>SOLANA BEACH, CALIFORNIA / ACCESS Newswire / September 25, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene therapy-enabling company offering precise navigation to the brain and spine, today announced that ...</description>
</item>
<item>
<title>ClearPoint Neuro Announces the Appointment of Dr. Paul Larson as Chief Medical Officer </title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-appointment-dr-paul-larson-chief-medical-officer-2025-09</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-appointment-dr-paul-larson-chief-medical-officer-2025-09</guid>
<pubDate>Thu, 25 Sep 2025 04:00:00 GMT</pubDate>
<description>SOLANA BEACH, CALIFORNIA / ACCESS Newswire / September 25, 2025 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global device, cell, and gene</description>
</item>
<item>
<title>ClearPoint Neuro Announces FDA Clearance Expanding Compatibility of the ClearPoint Prism Neuro Laser Therapy System with 1.5T MRI Scanners</title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-fda-clearance-expanding-compatibility-clearpoint-prism</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-fda-clearance-expanding-compatibility-clearpoint-prism</guid>
<pubDate>Thu, 04 Sep 2025 04:00:00 GMT</pubDate>
<description>SOLANA BEACH, CALIFORNIA / ACCESS Newswire / September 4, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene</description>
</item>
<item>
<title>ClearPoint Neuro Reports Second Quarter 2025 Results</title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-reports-second-quarter-2025-results-2025-08-12</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-reports-second-quarter-2025-results-2025-08-12</guid>
<pubDate>Tue, 12 Aug 2025 04:00:00 GMT</pubDate>
<description>Record Revenue and Substantial Cash Infusion Highlight the Company's ‘Fast. Forward.' Strategy SOLANA BEACH, CA / ACCESS Newswire / August 12, 2025 /</description>
</item>
<item>
<title>ClearPoint Neuro Announces Progression of Key Partner Milestones throughout the Global Biologics and Drug Delivery Portfolio</title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-progression-key-partner-milestones-throughout-global</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announces-progression-key-partner-milestones-throughout-global</guid>
<pubDate>Mon, 04 Aug 2025 04:00:00 GMT</pubDate>
<description>SOLANA BEACH, CALIFORNIA / ACCESS Newswire / August 4, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) ("Company"), a global device, cell, and gene</description>
</item>
<item>
<title>ClearPoint Neuro to Announce Second Quarter 2025 Results August 12, 2025</title>
<link>https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announce-second-quarter-2025-results-august-12-2025-2025-07-23</link>
<guid isPermaLink="true">https://6ix.com/company/clearpoint-neuro-inc/news/clearpoint-neuro-announce-second-quarter-2025-results-august-12-2025-2025-07-23</guid>
<pubDate>Wed, 23 Jul 2025 04:00:00 GMT</pubDate>
<description>SOLANA BEACH, CALIFORNIA / ACCESS Newswire / July 23, 2025 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global device, cell, and gene</description>
</item>
</channel>
</rss>